• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA TPE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA TPE SET Back to Search Results
Catalog Number 000000000000070500
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stacking Breaths (1593); Anaphylactic Shock (1703); Skin Irritation (2076)
Event Date 03/17/2014
Event Type  Injury  
Event Description
The customer reported that a patient had an anaphylactic reaction to the fresh frozen plasma(ffp) during a therapeutic plasma exchange (tpe) procedure.40 minutes into the procedure,the patient complained of shortness of breath and hives.The nurse disconnected the patient and the physician ordered iv benadryl in response to the patient reaction.Per the customer,the patient remained hospitalized following the event and is in stable condition.Customer declined to provide patient's identifier, age, and weight.The disposable kit is not available for return because it was discarded by the customer.This report is being filed due to medical intervention in the form of iv benadryl.
 
Manufacturer Narrative
Investigation: the disposable set was unavailable for return and investigation.The customer did not provide the lot number pertaining to this event, therefore, a device history record (dhr) search could not be conducted for this specific incident.All lots must meet acceptance criteria before release.A service call was placed and the machine was inspected.The machine was verified to be working as designed.Root cause: the kit was unavailable for specific root cause.The machine was evaluated and determined to be functioning as intended.Based on the spectra optia system functioning as intended and the customer's evaluation of the issue, the reaction was due to the patient's physiology.Per the therapeutic apheresis handbook: a physician's reference, 2nd edition, plasma replacement reactions may occur in approximately 7.8% of procedures, based on the results of a survey of therapeutic procedures.Of these reactions, most were mild and well tolerated.The spectra system has many safety features.A patient reaction can occur rapidly, however, it is imperative that the operator continuously monitor the spectra system and the patient.The spectra essentials guide contains further cautions and warnings for the user.
 
Manufacturer Narrative
This record was identified during a retrospective review of mdrs to identify records in which an event occurred, but the type of reportable event was not indicated appropriately.This supplement is being filed to modify information to align with the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBE SPECTRA BLOOD COLLECTION
Type of Device
COBE SPECTRA TPE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
jessica kim
10811 w. collins ave
lakewood, CO 80215
3032314812
MDR Report Key3754464
MDR Text Key4415673
Report Number1722028-2014-00122
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K831004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number000000000000070500
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/17/2014
Initial Date FDA Received04/16/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/29/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-